Our study intended to search the function and underlying mechanisms of BCYRN1, miR-490-3p, and POU3F2 in the progression of HCC, and expected to provide some useful molecules for targeted therapy of HCC. The gene discussed is POU3F2; the disease is hepatocellular carcinoma.